WHO warns of fake Ozempic medicines used for diabetes and weight loss
13 oC
13 oC
Güneşli
13 oC
Güneşli
The World Health Organization (WHO) issued a warning about counterfeit versions of semaglutide medications, including the brand name Ozempic.
These drugs are prescribed to manage type 2 diabetes and have become increasingly popular for weight loss, leading to a rise in counterfeiting.
The WHO identified three instances of falsified semaglutide products in October 2023 (Brazil and UK) and December 2023 (US). They urged healthcare professionals and the public to be cautious of these imitations.
Counterfeit semaglutide might lack essential ingredients, causing uncontrolled blood sugar levels or weight gain. In some cases, they may contain unlisted active ingredients like insulin, leading to unpredictable health risks.
While effective, semaglutide's high price makes it unsuitable for large-scale use in resource-limited settings. The WHO recommends more affordable medications with similar effects for diabetes management.
The WHO is developing rapid advice guidelines on using GLP-1 receptor agonists, including semaglutides, for treating obesity in adults as part of a comprehensive care model. GLP-1 RAs are a class of medicines that lower blood sugar and support weight loss.
The WHO urges all healthcare professionals, regulatory authorities, and the public to remain vigilant and report any suspicious medicines to the relevant authorities immediately. (ILKHA)
LEGAL WARNING: All rights of the published news, photos and videos are reserved by İlke Haber Ajansı Basın Yayın San. Trade A.Ş. Under no circumstances can all or part of the news, photos and videos be used without a written contract or subscription.
Türkiye’s Ministry of Health has introduced sweeping new regulations aimed at reducing the rate of medically unnecessary cesarean sections and promoting natural births, as part of its nationwide “Healthy Türkiye Century” initiative.
The Turkish Statistical Institute (TurkStat) reported Friday that Türkiye’s child population, aged 0-17, constituted 25.5% of the total population of 85.7 million in 2024, totaling 21.8 million children. Boys made up 51.3% of this group, and girls 48.7%.
The UN Special Rapporteur on the right to health, Tlaleng Mofokeng, has strongly condemned an Israeli airstrike on Al-Ahli Baptist Hospital, the last operational hospital in northern Gaza, which was struck on April 13, 2025.
Mexican health officials have confirmed the nation’s first human fatality from the H5N1 strain of avian influenza. The victim, a three-year-old girl from the northern state of Coahuila, passed away earlier this week due to complications from the virus, marking a sobering milestone in the country’s public health history.
